Skip to content
AnalystLens
Back to REGNBalance Sheet

Regeneron Pharmaceuticals Long-Term Debt 2010-2026 | REGN

Annual FY2010–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$1.99B

+0.1%YoY vs FY2024Source: 10-KFY2025

From $0 in FY2010 to $1.99B in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%Not reported
FY25$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%
FY24$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%
FY23$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%
FY22$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%$2.0B+0.1%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+0.1%

FY2020
$1.98B
FY2025
$1.99B

5 years selected · on the chart

01—History

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  13. $1.99B
YoY changeLargest recent move−54.2%in FY14Latest +0.1%

02—Ledger

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$1.99B+0.1%10-K
FY2024$1.98B+0.1%10-K
FY2023$1.98B+0.1%10-K
FY2022$1.98B+0.1%10-K
FY2021$1.98B+0.1%10-K
FY2020$1.98B—10-K
FY2019$0—10-K
FY2015$0−100.0%10-K
FY2014$146.8M−54.2%10-K
FY2013$320.3M+8.0%10-K
FY2012$296.5M+7.8%10-K
FY2011$275.0M—10-K
FY2010$0—10-K

03—Questions

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Regeneron Pharmaceuticals's current long-term debt?

Regeneron Pharmaceuticals (REGN) annual long-term debt for 2025 was $1.99B, a 0.08% increase from 2024. Regeneron Pharmaceuticals long-term debt for the quarter ending September 30, 2026 was $1.99B.

What was Regeneron Pharmaceuticals's long-term debt in 2024?

Regeneron Pharmaceuticals annual long-term debt for 2024 was $1.98B, a 0.08% increase from 2023.

What was Regeneron Pharmaceuticals's long-term debt in 2023?

Regeneron Pharmaceuticals annual long-term debt for 2023 was $1.98B, a 0.08% increase from 2022.

What is Regeneron Pharmaceuticals's 5-year long-term debt CAGR?

Regeneron Pharmaceuticals long-term debt grew at a compound annual growth rate (CAGR) of 0.07% from FY2020 to FY2025, going from $1.98B to $1.99B over 5 years.

Company
Regeneron Pharmaceuticals
Ticker
REGN
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →